Publications

Export 41 results:
Sort by: [ Author  (Desc)] Title Type Year
A B C D [E] F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
E
Esmat, S. M., M. R. E. Abdel-Halim, H. I. GAWDAT, M. Kamel, A. E. Ramly, K. Helmy, and S. M. Esmat, "Persistent Pixel Stamping Marks: a novel complication of fractional CO laser in scar treatment.", Lasers in medical science, 2019 Jan 04. Abstract

Fractional CO laser rejuvenation of scars offers a high safety profile. Laser marks usually disappear clinically within 1 week. The authors observed occasional persistence of the laser marks on the scar surface. The purpose of this study is to report the incidence and to describe the clinical, dermoscopic, and histological features of a novel observed complication of fractional CO laser scar rejuvenation "Persistent Pixel Stamping Marks (PPSM)".One hundred seventy-one cases were consecutively recruited from patients assigned for fractional CO laser scar rejuvenation. Patients who developed the phenomenon 1 month post laser session were recorded and subjected to clinical photography, dermoscopy, and optical coherence tomography (OCT) as well as a 4-mm punch biopsy from pixelated scars. The evolution of PPSM was followed up for 6 months. PPSM developed in 16 patients (9.4%), 15 of which were post burn hypertrophic scars. PPSM was significantly related to darker skin type, darker scar color, and longer scar duration. Histopathological findings included characteristic holes in stratum corneum and superficial dermis, thick collagen bundles perpendicular to the skin surface with loss of elastic tissue, focal interface changes, and triangular focus of fibroblastic proliferation. The marks disappeared in 5 and lasted in 11 patients. Their longevity was significantly related to longer dwell times and lower densities. PPSM represent miniature scarring at the sites of the microscopic thermal zones or a sign of their delayed healing. They tend to follow fractional CO laser resurfacing of hyperpigmented, long-standing burn scars. Longer dwell times and lower densities make them last longer.

Esmat, S., M. R. E. Abdel-Halim, A. El-Tawdy, M. M. Fawzy, A. Ragheb, and N. Hasan, "Does increasing the pulse duration increase the efficacy of long pulsed Nd: YAG laser assisted hair removal? A split-chin clinical trial", European Journal of Dermatology, vol. 1, no. 1, pp. 0–0, 2014. Abstract
n/a
Esmat, S., M. AbdElhalim, M. Fawzy, S. Nassef, S. Esmat, R. T. Fouly ES, and El, "Are normolipidaemic patients with xanthelasma prone to atherosclerosis?", Clinical and Experimental Dermatology, 2015. Abstract
n/a
Esmat, S. M., M. R. E. Abdel-Halim, M. M. Fawzy, and H. Shehata, "Low-power carbon dioxide laser and conventional electrosurgery in the treatment of verrucae vulgaris: which stands first?", Journal of the Egyptian Women’s Dermatologic Society, vol. 9, no. 3: LWW, pp. 136–143, 2012. Abstract
n/a
Enany, G. E., N. Nagui, H. Nada, H. A. Abdelkader, I. Sany, A. Nada, M. Mostafa, O. El-Ghanam, and M. R. E. Abdel-Halim, "Crystalglobulinemia: A Rare Presenting Manifestation of Multiple Myeloma.", The American Journal of dermatopathology, 2021. Abstract

ABSTRACT: Crystalglobulinemia (CG) is a rare disorder characterized by crystallization of monoclonal immunoglobulins in the microcirculation leading to multiorgan vascular thrombosis and ischemic injury. The main cause of CG is multiple myeloma. We report a case of a 52-year-old man who presented with widespread necrotizing plaques and ulcerations. A skin biopsy revealed eosinophilic rectangular-shaped crystals occluding the lumina of blood vessels with no associated features of vasculitis. The crystals were Periodic acid-Schiff stain positive. The findings were diagnostic of CG. Extensive work up lead to the discovery of multiple myeloma. Awareness of CG is important because it may be the first presenting manifestation of an underlying serious hematological malignancy.

Enany, G. E., K. E. Hoshy, R. Yousef, H. Nada, M. Abdel-Halim, A. Nada, D. A. Antably, and I. Sany, "Fluorscopy induced chronic radiodermatitis: three cases presenting after cardiac catheterization.", JEWDS, vol. 18, issue 2, pp. 153-156, 2021.
Enany, G. E., N. Nagui, H. Nada, S. Shalaby, I. Sany, A. Nada, S. Orabi, O. El Ghanam, and M. R. E. Abdel-Halim, "Widespread Keratotic Spiky Follicular Papules Associated With Hyperpigmentation: Answer.", The American Journal of dermatopathology, vol. 42, issue 10, pp. 787-788, 2020.
Enany, G. E., H. Nada, N. Nagui, I. Sany, A. Nada, S. Ibrahim, O. EGhannam, and M. R. E. Abdel-Halim, Diffuse cicatricial alopecia and multiple telangiectatic indurated leg plaques, , 2020.
Elsayed, H., S. SHALABY, M. R. E. Abdel-Halim, D. M. Aboelfadl, and N. Samir, "Efficacy of doxycycline in the treatment of early stages of mycosis fungoides: a randomized controlled trial.", The Journal of dermatological treatment, pp. 1-8, 2019. Abstract

Mycosis fungoides is the most common type of primary cutaneous T cell lymphomas. Doxycycline promoted apoptosis in different human malignant cell lines and in vivo models. To test for the therapeutic efficacy of doxycycline in comparison to PUVA in early stages of classic MF and its effect on T cell apoptosis. Thirty-six patients were randomized into either: doxycycline 200 mg daily ( = 18) or PUVA (3 weekly sessions) ( = 18) for 12 weeks. The primary outcome (therapeutic efficacy) was defined in terms of objective response rate (ORR) which was measured according to changes in the modified severity weighted assessment tool (mSWAT). Doxycycline achieved significantly less ORR (partial response) in comparison to PUVA (11.1%, 50%, respectively,  = .016). The percent reduction in mSWAT, CAILS, histopathology score and CD3 expression was significantly less in the doxycycline group ( = .001,  = .001,  ˂ .001, and  = .004, respectively). Within the doxycycline group, changes in mSWAT and CAILS showed no correlation with changes in the CD3 or Bcl-2 expression. Gastric upset was significantly more encountered in the doxycycline group ( = .001). Doxycycline is not suitable as a sole agent in the treatment of early stages of classic MF, acting mainly by anti-inflammatory rather apoptotic function. NCT03454945 ( www.clinicaltrials.gov ).

Elbendary, A., R. Youssef, M. R. E. Abdel-Halim, D. abd el halim, D. A. El Sharkawy, M. Alfishawy, M. A. Gad, A. A. Gad, and M. F. Elmasry, "Role of streptococcal infection in the etiopathogenesis of pityriasis lichenoides chronica and the therapeutic efficacy of azithromycin: a randomized controlled trial.", Archives of dermatological research, 2022. Abstract

The exact aetiology of pityriasis lichenoides chronica (PLC) remains unknown. While phototherapy is the most investigated therapeutic modality, azithromycin has been used scarcely. The aim of this study is to evaluate the therapeutic efficacy of azithromycin in the treatment of PLC compared to NB-UVB and evaluating the presence of streptococcal infection as a possible etiological factor in PLC patients. The study was designed as a randomised controlled trial. Twenty-four patients with PLC were randomly allocated into either azithromycin (n = 13, standard dose every 10 days) or NB-UVB (n = 11, thrice weekly) groups. End of study (EOS) was either complete clearance of lesions or a maximum of 8 weeks. Therapeutic efficacy was defined as percent reduction in lesions and was calculated for the rash as a whole, erythematous papules alone, and hypopigmented lesions alone and graded into complete, very-good, good, poor or no response. Anti-streptolysin O titre (ASOT), anti-deoxyribonuclease B titre (anti-DNaseB) and throat culture were evaluated at day 0. No significant difference existed between both groups as regards therapeutic efficacy. At EOS, NB-UVB achieved significantly more percent reduction in the extent of hypopigmented lesions and consequently in the rash as a whole (p = 0.001, p = 0.034, respectively). The extent of the rash as a whole was significantly less in the NB-UVB at EOS (p = 0.029, respectively). The effect of NB-UVB on hypopigmented lesions appeared early at week 4 of treatment. Only two patients, one from each group, relapsed during the 3 month follow-up. Evidence of recent streptococcal infection was present in 79% of the cases, mainly in the form of elevated ASOT (94.7%). It was significantly more encountered in young children (< 13 years) (p = 0.03) and was associated with more extent of erythematous papules and consequently with more extent of the rash as a whole (p = 0.05 and p = 0.01, respectively). It did not affect outcome of therapy at EOS. Azithromycin did not show more favorable response in patients with recent streptococcal infection. Therapeutic efficacy of azithromycin is comparable to NB-UVB in treatment of PLC; however, NB-UVB is superior in management of hypopigmented lesions. It is highly suggested that PLC could be a post streptococcal immune mediated disorder.Registration number: ClinicalTrials.gov, NCT03831269.

Elbendary, A., M. R. E. Abdel-Halim, R. Youssef, D. abd el halim, M. F. Elmasry, A. A. Gad, and D. A. El Sharkawy, "Hypopigmented lesions in pityriasis lichenoides chronica patients: Are they only post-inflammatory hypopigmentation?", The Australasian journal of dermatology, 2021. Abstract

BACKGROUND/OBJECTIVES: Pityriasis lichenoides chronica (PLC) lesions are reported to subside with post-inflammatory hypopigmentation (PIH); hence, the most widely perceived nature of hypopigmented macules in PLC is PIH. However, to the best of our knowledge, no studies describing histopathological findings in these lesions are reported in literature. The aim of this study is to evaluate the hypopigmented lesions encountered in PLC patients and to shed light on their histopathological features.

METHODS: A cross-sectional observational study included twenty-one patients with PLC recruited in a period of twelve months. Clinical characteristics of each patient were collected. A skin biopsy from hypopigmented lesions whenever present was taken and assessed with routine haematoxylin and eosin stain.

RESULTS: Seventeen patients (81%) were less than 13 years old. Most patients (85.7%) demonstrated diffuse distribution of lesions. Hypopigmented lesions were present on the face in 12 (57.14%) patients. Histopathologically, hypopigmented lesions showed features of post-inflammatory hypopigmentation in 19% of patients, residual PLC in 52.4% and active PLC 28.6% of patients.

CONCLUSION: Hypopigmented lesions in PLC were noted mainly in younger ages, histopathologically they may show features of active or residual disease, beyond post-inflammatory hypopigmentation. Consequently active treatment for patients presenting predominantly with hypopigmented lesions could be required to control the disease.

Elbendary, A., H. A. Abdelkader, Y. Abdel-Galeil, M. El-Mofty, A. M. Sultan, A. S. Elkomi, and M. R. E. Abdel-Halim, "Cytoplasmic CD3 Positivity as the Only Clue for the Diagnosis of T-Acute Lymphoblastic Leukemia With Cutaneous Deposits: A Case Report.", The American Journal of dermatopathology, vol. 42(1), pp. 43-45, 2020.
Elbendary, A., M. R. E. Abdel-Halim, and G. Ragab, "Updates in cutaneous manifestations of systemic vasculitis.", Current opinion in rheumatology, vol. 34, issue 1, pp. 25-32, 2022. Abstract

PURPOSE OF REVIEW: The main purpose of this review is to present newly reported cutaneous manifestations of systemic vasculitis, updates in investigations to verify systemic involvement in cases with cutaneous vasculitis and new therapeutic guidelines. The spectrum of COVID-19-related vasculitis is also covered.

RECENT FINDINGS: Only a few reports highlighted new cutaneous presentations or associations with some systemic vasculitic entities. For example, the association of inflammatory disorders with Takayasu arteritis, the importance of considering Kawasaki disease in febrile children with erythema nodosum, the development of necrotic ulcers on fingers and toes in Behçet's disease and the possible presence of polyarteritis nodosa-like pathological features in vulvar ulcers of Behçet's disease. New attempts to classify cutaneous manifestations of giant cell arteritis (GCA) and antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and the diagnostic investigations for cutaneous vasculitis cases to verify systemic involvement are discussed. Treatment of systemic vasculitis with cutaneous vasculitis should be tailored according to disease status. A plethora of reports in the past 2 years focused on the broad spectrum of COVID-19 vasculitic manifestations.

SUMMARY: Although newly reported cutaneous manifestations of systemic vasculitis are relatively uncommon, the plethora of reports in the past 2 years on COVID-19 vasculitis necessitates the expansion of the classification of vasculitis associated with probable cause to include severe acute respiratory syndrome coronavirus-2 (SARS-Cov-2) vasculitis.

El-Tahlawi, S. M. R., M. R. E. Abdel-Halim, M. A. F. Hamid, K. S. Mohammad, H. Wafai, and A. H. M. S. El-Sayed, "Gene polymorphism and serum levels of insulin-like growth factor-I in Egyptian acne patients", Journal of the Egyptian Women’s Dermatologic Society, vol. 11, no. 1: LWW, pp. 45–49, 2014. Abstract
n/a
El-Nabarawy, E. A., A. E. L. Tawdy, M. Atteia, S. Shalaby, M. Amer, M. R. E. Abdel-Halim, M. M. Fawzi, M. A. Saleh, S. Ibrahim, and M. Abdallah, "Granular cell tumor: a report of three cases with different clinical presentations.", JEWDS, vol. 13, no. 1, pp. 43–45, 2016. Abstract
n/a
El-Nabarawy, E. A., N. Saleh, and M. R. E. Abdel-Halim, "Peculiar papular eruption on the vulva and inguinal folds.", Journal of clinical pathology, vol. 72, issue 2, pp. 185, 2018 Dec 20, 2019. Abstract

CLINICAL QUESTION: A 26-year-old woman presented with asymptomatic skin coloured to whitish keratotic papules on the vulva, inguinal folds and inner thighs of 6 years duration. She had no similar lesions elsewhere and no family history. A biopsy was taken from one of the papules.Review the high-quality, interactive digital Aperio slide at http://virtualacp.com/JCPCases/jclinpath-2018-205434/ and consider your diagnosis. WHAT IS YOUR DIAGNOSIS?: Darrier's diseaseHailey-Hailey diseaseGenital wartsPapular acantholytic dyskeratosis of genitocrural areaPemphigus vegetansThe correct answer is after the discussion.

DISCUSSION: Papular acantholytic dyskeratosis (PAD) of the genitocrural area is a peculiar acantholytic dermatosis with dyskeratosis localised to the vulva and inguinal folds with possible extension to the thighs and perineum.1 It mainly involves young or middle-aged females.1 Cases affecting males and involving genitalia, thighs and perianal region have been reported.2 It represents an allelic variant of Hailey-Hailey disease as heterozygous mutations in gene (intron 5 and exon 24) have been reported in some cases.3 Clinically, PAD of the genitocrural area is typically characterised by solitary or grouped keratotic flesh coloured or white papules.1 Other clinical presentations include: vesicles, bullae, patches and plaques.4 Although the lesions are mainly asymptomatic, patients may experience variable degrees of itching or burning sensation.Histopathologically, the lesions show hyperkeratosis, hypergranulosis, acanthosis and acantholytic dyskeratosis in the spinous layer (figure 1). Typically, direct immunoflourescence (DIF) is negative.5 jclinpath;jclinpath-2018-205434v1/F1F1F1Figure 1Photomicrograph representing histopathological findings: hyperkeratosis, hypergranulosis, acanthosis and acanthloytic dyskeratosis involving the spinous layer; 254×143 mm.The most important differential diagnoses of this sporadic condition include: Darier's and Hailey-Hailey, both of which are familial. Hailey-Hailey involves also other flexural areas and presents with eroded crusted lesions with foul odour. Pathologically, the acantholytic process in PAD of the genitocrural area is rather focal compared with the broad zone of acantholysis in Hailey-Hailey, and columns of parakeratosis overlying suprabasilar acantholysis are characteristic of Darier's disease. Although, some cases of PAD of the genitocrural area can present with vesicles and bullae, the presence of dyskeratotic cells and the negative DIF speaks against pemphigus.Treatment options for this condition include topical and systemic retinoids. Cryotherapy and laser have been also reported to be effective. Topical steroids might be effective in reducing pruritus.

El-Mofty, M., H. El Weshahy, R. Youssef, M. Abdel-Halim, H. Mashaly, and M. El Hawary, "A comparative study of different treatment frequencies of psoralen and ultraviolet A in psoriatic patients with darker skin types (randomized-controlled study)", Photodermatology, photoimmunology & photomedicine, vol. 24, no. 1: Wiley Online Library, pp. 38–42, 2008. Abstract
n/a
El-Mofty, M. A., S. M. Esmat, and M. R. E. Abdel-Halim, "Pigmentary disorders in the Mediterranean area", Dermatologic clinics, vol. 25, no. 3: Elsevier, pp. 401–417, 2007. Abstract
n/a
El-Mofty, M., M. El-Darouti, H. RASHEED, D. A. Bassiouny, M. Abdel-Halim, N. S. Zaki, G. El-Hanafy, H. El-Hadidi, O. Azzam, A. El-Ramly, et al., "Sulfasalazine and pentoxifylline in psoriasis: a possible safe alternative", Journal of Dermatological Treatment, vol. 22, no. 1: Informa Healthcare USA on behalf of Informa UK Ltd. London, pp. 31–37, 2011. Abstract
n/a
El-Mofty, M., W. Z. Mostafa, R. Yousef, M. R. E. Abdel Halim, M. El Hawary, H. Abdel Kader, S. Assaad, and B. B. Ghannam, "Broadband ultraviolet A in the treatment of psoriasis vulgaris: a randomized controlled trial", International journal of dermatology, 2014. Abstract
n/a
EL-KOMY, M. O. H. A. M. E. D. H. U. S. S. E. I. N. M. E. D. H. A. T., M. R. Abdel-Halim, E. A. El-Nabarawy, S. El-Tobshy, S. Shalaby, and A. I. Kamel, "Subungual nodule with recurrent bleeding", Journal of the American Academy of Dermatology, vol. 67, no. 5: Mosby, pp. e229–e230, 2012. Abstract
n/a
El-Komy, M. H. M., Y. Azzazi, R. El Naggar, and M. R. E. Abdel-Halim, "Chronic Atrophic Scar-like Plaque: Challenge.", The American Journal of dermatopathology, vol. 44, issue 1, pp. e6-e7, 2022.
El-Komy, M. H. M., N. Shawky, A. Mourad, and M. R. Abdel-Halim, "Erythema gyratum repens-like psoriasis: a case report and review of literature.", International journal of dermatology, 2022.
El-Hoshy, K., M. R. E. Abdel-Halim, D. Dorgham, S. S. E. - D. Sayed, and M. El-Kalioby, "Efficacy of Fractional Carbon Dioxide Laser in the Treatment of Mature Burn Scars: A Clinical, Histopathological, and Histochemical Study.", The Journal of clinical and aesthetic dermatology, vol. 10, issue 12, pp. 36-43, 2017 Dec. Abstract

The purpose of this study was to evaluate the efficacy of fractional carbon dioxide laser use in the treatment of mature burn scars. This was an uncontrolled, open-label clinical trial. The setting for this study was Dermatology Department at Cairo University in Cairo, Egypt. Twenty patients with mature burn scars were included in the study. Three fractional carbon dioxide laser sessions were given, 4 to 8 weeks apart. Primary outcome was measured using two scar scales, the Vancouver Scar Scale and the Patient and Observer Scar Assessment Scale. Secondary outcomes included evaluation of collagen and elastic fibers using routine hematoxylin and eosin, Masson's trichrome, and orcein stains. Outcomes were measured two months after the last laser session. Both Vancouver Scar Scale and Patient and Observer Scar Assessment Scale showed significant reduction following treatment (<0.001). Scar relief and pliability improved most followed by vascularity. Pigmentation improved the least. Percent improvement in Patient and Observer Scar Assessment Scale patients' overall assessment was 44.44 percent. The pattern and arrangement of collagen and elastic fibers showed significant improvement (<0.001, =0.001, respectively), together with significant improvement in their amounts (=0.020, <0.001, respectively). No significant correlation existed between clinical and histopathological/histochemical scores. Side effects and complications were mild and tolerable. Fractional carbon dioxide laser use is an effective and safe method for treating burn scars with a significant change in the opinion of the patients about their scar appearance.

El-Hawary, M. S., M. R. E. Abdel-Halim, S. S. Sayed, and H. A. Abdelkader, "Apocytolysis, a proposed mechanism of blister formation in epidermolysis bullosa simplex", Archives of Dermatological Research: Springer Berlin Heidelberg, pp. 1–7, 2015. Abstract
n/a